Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia

NCT01231607 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

917

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenetic Alopecia

Interventions

DRUG: 1mg Finasteride active
DRUG: 0.02mg dutasteride
DRUG: 0.1mg dutasteride
DRUG: 0.5mg dutasteride
DRUG: Finasteride placebo
DRUG: Dutasteride placebo

Sponsor

GlaxoSmithKline